Iron Sorbitol Citric Acid Complex

Global Calcium is one of the leading manufacturers and exporters of Iron Sorbitol Citric Acid Complex CAS no. 1338-16-5, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Iron Sorbitol Citric Acid Complex we hereby state the following facts about the drug:

Indications for Use

Iron-sorbitol citric acid complex is an effective parenteral agent for the treatment of patients with iron deficiency anemia who cannot be treated satisfactorily with oral iron salts.

Drug Information

This compound has an average molecular weight of 5,000. It is prepared to contain 50 mg of iron/ml of which 8% is dialyzable. TFor those situations in which oral iron is not suitable for the treatment of iron-deficiency states, an ironsorbitol-citric acid complex for intramuscular use is now available. This preparation has been demonstrated to have no carcinogenic effect in test animals. Because of its small molecular size it is rapidly absorbed via the capillary bed from the site of injection, and does not result in local staining or induration and pain. No severe generalized reactions were noted despite its rapid absorption. Local reactions were minimal and by and large were felt to be those associated with any deep intramuscular injection. In the suboptimal treatment doses given in this survey, this preparation produced the maximal rise in hemoglobin for the amount of elemental iron injected. If given in large enough doses, carefully calculated to restore hemoglobin values and iron stores to normal levels, it should prove to be a safe, clinically effective parenteral agent for the therapy of iron-deficiency.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market